Streamlined Operations, Increased Revenue, Higher Quality of Care: Conclusive Evidence on the Value of Adopting Digital Pathology in Your Lab


FREE Webinar
Held Wednesday, May 13 at 1 PM EDT

Now a Streaming Webinar

Digital pathology has been positioned as a
transformational tool that is enabling anatomic pathology laboratories to effectively address the complex dynamics that threaten their economic viability. A growing base of both partially and fully digitized labs continues to generate evidence in support of this paradigm shift.

The verdict is in: Labs that have adopted digital pathology have seen from 13 to 21% efficiency and productivity gains.

This same story is playing out for labs that have implemented artificial intelligence-enabled digital workflows. As the potential for computational pathology applications has become increasingly clear, leading laboratories are racing to build strategies to realize the positive clinical and economic impacts to even their routine casework—benefits such as increased efficiency, improved productivity, better margins, and a consistently higher quality of care.

In this era of increasingly personalized medicine, understanding the transformational power of digital pathology is critical. It also couldn’t be timelier as laboratories navigate the global pandemic and look to digitization to support their remote workforces. That is why you’ll want to stream this FREE webinar, “Streamlined Operations, Increased Revenue, Higher Quality of Care: Conclusive Evidence on the Value of Adopting Digital Pathology in Your Lab,” that took place Wednesday, May 13 at 1 PM EDT.

During this insightful webinar, you’ll hear from leading industry experts and pathologists who will share their lessons learned and best practices on the meaningful adoption and scale up of digital and computational pathology.


Now a Streaming Webinar


Attend this 60-minute program, and you will:

  • Recognize the return of going digital in terms of workflow, outcomes, and cost
  • Identify approaches and considerations for digital adoption, including technology requirements
  • Understand how early adopters have leveraged digital and AI to address growing pressures on their labs
  • Learn best practices for using digital pathology to support a remote workforce during these uncertain times and much more

Who should attend?

  • Laboratory Owners
  • Laboratory Senior Management
  • Pathologists interested in going digital
  • Anatomic Pathology Laboratory Managers and Administrators looking to expand their digital laboratories

Your registration includes:

  • A site license to attend the webinar. Invite as many members of your team as you would like!

Now a Streaming Webinar

 Sponsored by:


Hosted by:






Your Panel:

Anthony M. Magliocco, MD.

Anthony M. Magliocco, MD,
President and CEO
Protean BioDiagnostics
Tampa, FL

Magliocco is an internationally recognized cancer expert with over 30 years of experience in creating and deploying advanced diagnostics to help cancer patients. He is board certified in pathology and has held multiple leadership positions in Canada and the US, including Professor and Chair of Pathology at Moffitt Cancer Center and Executive Director of Esoteric Laboratory Services at Moffitt between 2011 and 2019. He also served as Scientific Director of Moffitt’s internationally renowned tissue bank between 2011 and 2019. He has founded new fellowships in molecular diagnostics and digital image analysis, and directed the CAP CLIA implementation of the Moffitt STAR(TM) NGS assay. Magliocco has published over 200 manuscripts with more than 10,000 citations.


Nathan Buchbinder

Nathan Buchbinder
Chief Product Officer
Philadelphia, PA


Buchbinder is an industry pioneer and thought leader in AI and the digitization of pathology. He co-founded Proscia, a leading digital and computational pathology software company in 2014, where he currently serves as the Chief Product Officer. During his tenure, Proscia has earned recognition as a category leader, bringing to market best-in-class image management software and artificial intelligence applications for laboratory medicine.